Treatment of Bone Metastases of Breast Cancer With 177Lu-DOTA-IBA

We report a case of recurrent intermittent pain due to bone metastasis, who demonstrated a satisfactory therapy response after 2 cycles of 177Lu-DOTA-IBA. In addition, the patient did not have any observable adverse effects.PMID:38537210 | DOI:10.1097/RLU.0000000000005193
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Source Type: research